Omniscient Treatment Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -54.14%
(FY 2022)
- Profit -67.39%
(FY 2022)
- Ebitda -66.22%
(FY 2022)
- Net Worth 7.28%
(FY 2022)
- Total Assets -33.25%
(FY 2022)
About Omniscient Treatment Technologies
The Company is engaged in the Consumer Electronics & Durables Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Waindeskar and Rajesh Admane serve as directors at the Company.
- CIN/LLPIN
U29199MH2006PTC164776
- Company No.
164776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Omniscient Treatment Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Waindeskar  | Director | 29-Sep-2006 | Current |
| Rajesh Admane | Director | 29-Sep-2006 | Current |
Financial Performance and Corporate Structure Insights of Omniscient Treatment Technologies.
Omniscient Treatment Technologies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 54.14% decrease. The company also saw a substantial fall in profitability, with a 67.39% decrease in profit. The company's net worth moved up by a moderate rise of 7.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omniscient Treatment Technologies?
In 2020, Omniscient Treatment Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ozone Research And Applications (India) Private LimitedActive 22 years 7 monthsVishal Waindeskar and Rajesh Admane are mutual person
Ozone Crop Innovate Private LimitedActive 7 months 5 daysVishal Waindeskar and Rajesh Admane are mutual person
- Fly Ash Benefactor Private LimitedActive 24 years 7 months
Vishal Waindeskar and Rajesh Admane are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Omniscient Treatment Technologies?
Unlock and access historical data on people associated with Omniscient Treatment Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omniscient Treatment Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omniscient Treatment Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
